Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 1321 AL 1335

[FALLS IN PATIENTS WITH DEMENTIA]

Aizen E.

Harefuah. 2015 May;154(5):323-6, 338.

Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery

John AA, Subramanian AP, Vellayappan MV, Balaji A, Mohandas H, Jaganathan SK.

Int J Nanomedicine. 2015 Jul 2;10:4267-77. doi: 10.2147/IJN.S83777. eCollection 2015.

Connexin: a potential novel target for protecting the central nervous system?

Xie HY, Cui Y, Deng F, Feng JC.

Neural Regen Res. 2015 Apr;10(4):659-66. doi: 10.4103/1673-5374.155444.

[Current possibilities of quality of life improvement in the late stages of Parkinson's disease]

Titova NV, Katunina EA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(3):94-100. doi: 10.17116/jnevro20151153194-100.

Sex Differences in Clinical Features of Early, Treated Parkinson's Disease

Augustine EF, Pérez A, Dhall R, Umeh CC, Videnovic A, Cambi F, Wills AM, Elm JJ, Zweig RM, Shulman LM, Nance MA, Bainbridge J, Suchowersky O.

PLoS One. 2015 Jul 14;10(7):e0133002. doi: 10.1371/journal.pone.0133002. eCollection 2015.

Early Neurodegeneration in the Brain of a Child Without Functional PKR-like Endoplasmic Reticulum Kinase

Bruch J, Kurz C, Vasiljevic A, Nicolino M, Arzberger T, Höglinger GU.

J Neuropathol Exp Neurol. 2015 Aug;74(8):850-7. doi: 10.1097/NEN.0000000000000224.

Can Patients with Parkinson's Disease Use Dry Powder Inhalers during Off Periods?

Luinstra M, Rutgers AW, Dijkstra H, Grasmeijer F, Hagedoorn P, Vogelzang JM, Frijlink HW, de Boer AH.

PLoS One. 2015 Jul 14;10(7):e0132714. doi: 10.1371/journal.pone.0132714. eCollection 2015.

Parkinson's Disease, Religion, and Spirituality

Redfern C, Coles A.

Mov Disord Clin Pract. 2015 Jul 15;2(4):341-346. doi: 10.1002/mdc3.12206. eCollection 2015 Dec.

Identifying the components of clinical vignettes describing Alzheimer's disease or other dementias: a scoping review

Randhawa H, Jiwa A, Oremus M.

BMC Med Inform Decis Mak. 2015 Jul 15;15:54. doi: 10.1186/s12911-015-0179-x.

Protective Effects of Physical Exercise in Alzheimer's Disease and Parkinson's Disease: A Narrative Review

Paillard T, Rolland Y, de Souto Barreto P.

J Clin Neurol. 2015 Jul;11(3):212-9. doi: 10.3988/jcn.2015.11.3.212.

Orthostatic Hypotension: Mechanisms, Causes, Management

Low PA, Tomalia VA.

J Clin Neurol. 2015 Jul;11(3):220-6. doi: 10.3988/jcn.2015.11.3.220.

[Camptocormia and Parkinson's disease: association or consequence?]

Frioui S, Jemni S.

Pan Afr Med J. 2015 Apr 9;20:339. doi: 10.11604/pamj.2015.20.339.6586. eCollection 2015.

Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy

Domanskyi A, Saarma M, Airavaara M.

Hum Gene Ther. 2015 Aug;26(8):550-9. doi: 10.1089/hum.2015.065.

Basic science breaks through: New therapeutic advances in Parkinson's disease

Brundin P, Atkin G, Lamberts JT.

Mov Disord. 2015 Sep 15;30(11):1521-7. doi: 10.1002/mds.26332. Epub 2015 Jul 16.

Chemical biology of compounds obtained from screening using disease models

Tashiro E, Imoto M.

Arch Pharm Res. 2015 Sep;38(9):1651-60. doi: 10.1007/s12272-015-0633-4. Epub 2015 Jul 17.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias